Back to Companies
RECURSION PHARMACEUTICALS, INC.
RXRXNasdaqCIK: 0001601830
RECURSION PHARMACEUTICALS, INC. (RXRX) shows 50 recent insider filings from 11 insiders, with all of them on the sell side. With $0 in purchases and $4.9M in sales, the recent tape is heavily weighted toward selling (net sales of $4.9M). Borgeson Blake (Director) is the most active by dollar volume, and the single largest transaction was $959.2K by Borgeson Blake. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$6.4M
Purchases
$0
Sales
$4.9M
Unique Insiders
11
Recent Insider Trades
50 loaded
| Aug 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Tax withheld | $79.1K |
| Aug 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Tax withheld | $254.4K |
| Aug 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $84.2K |
| Aug 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $97.5K |
| Jul 9 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $158.5K |
| Jul 2 | RXRX RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Director | Grant | $0 |
| Jul 2 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $12.6K |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Sun Elaine D | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Michor Franziska | Director | Grant | $0 |
| Jun 17 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Tax withheld | $17.0K |
| Jun 5 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Sell | $84.5K |
| Jun 5 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.8K |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $15.5K |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $110.4K |
| May 27 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $123.2K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Tax withheld | $69.4K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $81.0K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Tax withheld | $76.1K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Tax withheld | $190.6K |
| May 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $134.8K |
| May 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $105.6K |
| Apr 24 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.4K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $93.0K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $124.0K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Tax withheld | $149.4K |
| Mar 25 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $130.0K |
| Mar 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $27.0K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Tax withheld | $49.8K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $138.4K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $41.4K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $41.6K |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Grant | $41.2K |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Grant | $45.4K |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Grant | $45.4K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $164.8K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $924.0K |
| Jan 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $178.8K |
| Jan 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $959.2K |
| Jan 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $170.0K |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Director | Grant | $0 |
| Dec 30 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $89.4K |
| Dec 29 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | Chief R&D Commercial Officer, Director | Sell | $548.6K |
| Dec 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $180.0K |
| Dec 17 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Tax withheld | $30.6K |
50 filings+